Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Smart Scale-Up:Expanding Viral Vectors with Microcarrier Bead Technology | Contract Pharma

What are you searching for?

Sign in
White Papers / Tech Papers

Smart Scale-Up:Expanding Viral Vectors with Microcarrier Bead Technology

Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

Released By IDT Biologika

As health professionals administer the Pfizer-BioNTech and Moderna mRNA-based COVID-19 vaccines, other companies are working to develop viral vector-based vaccines to combat coronavirus and other viral diseases. Viral vectors require cells to grow, but certain viral vectors can only be produced on adherent cell cultures, while others can also be produced on suspension cell cultures. Vaccine manufacturers often encounter significant challenges in scaling up the adherent cell cultures used for these treatments, and novel technologies are needed to facilitate safe, rapid production.

Download White Papers / Tech Papers Now

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters